4YFN – Interview with Gemma Malla of Angelini Pharma

Barcelona Health Hub returns once again to 4YFN 2023, the startup business platform at the Mobile World Congress next month. At the BHH stand you’ll explore cutting-edge technologies, new tendencies and future solutions, provided by the BHH members.

One of the companies you can meet at 4YFN, is long-time BHH member Angelini Pharma. Angelini Pharma has more than 100 years of history is present today in more than 5 million homes in Spain and commercializes in 70 countries with a total of more than 3.000 employees. Dynamic and restless Angelini Pharma has a strong focus in Brain Health, but is also a leading player in Consumer Health segment, with successful OTC brands such as Thermacare or Juanola.

Today we meet with Gemma Malla, Head of Digital of Angelini Pharma, who will share with us more about their expectations for this edition of 4YFN.

Gemma, thank you for joining Barcelona Health Hub! We’re looking forward to seeing you at the BHH stand at 4YFN. Can you please introduce yourself and tell us about Angelini Pharma?

I built my career as strategic consultant at Deloitte Digital where I advised companies from different sectors such as Banking, Fast Consumer Goods, Retail and above all, pharma companies implement their digital strategy. In 2020, in the middle of the pandemic, I joined Angelini Pharma to lead the company’s digital transformation in Spain and Portugal as Iberia Digital Head. I love making change happen and that is why I joined Angelini Pharma, a European leader in Brain Health, where we work with dynamism, agility and passion to pursue how digital can help innovate and take people’s brain health one step further.

Can you elaborate about what’s new at Angelini Pharma these days?

In Angelini we are writing the next chapter for Brain health every day, working for our patients which are our North Star. We know psychiatric and neurological disorders will be the real challenge of the future. And that is why we have recently launched a disruptive treatment in epilepsy, since it is estimated that every year, only in Spain, 400,000 people suffer from epilepsy, a chronic disease that affects more than 50 million people in the world.

BHH is glad to see you present at the digital health area of Barcelona Health Hub. Could you share why you decided to join Barcelona Health Hub at 4YFN?

On the one hand, we have been members of BHH for more than 2 years now, because we believe the true value delivered to patients about digital and innovation cannot be done alone, but in a true ecosystem. Where HCPs, patients’ associations, HCOs, start-ups and pharma companies collaborate as one. And in this sense BHH does a great job, putting together different stakeholders and leaving place for value creation together.

On the other hand, the MWC and 4YFN are worldwide referent events where innovation happens: we as a company cannot aspire to deliver innovation and digital disruption to our patients if we do not keep our eyes open, staying always curious to the cutting-edge technologies and advances that are presented during these days.

You’re also participating in the #BHHPanel about “Digital Disruption in Pharma”. Can you tell us what would be your key message at the panel?

Digital disruption can happen at 4 layers: 1) It can help companies gain efficiencies, 2) engage better with their clients/stakeholders, 3) innovate in digital services beyond the pill and that can only happen if 4) there is true digital mindset. In Angelini Pharma we are leveraging the four pillars with different weights according to our strategy and in the panel, we will be sharing with special focus how we worked in digital mindset by changing the entire organization and working PLAY, dynamic and agile methodologies to have a digital un precedent launch in epilepsy field.

What are you excited about these days at the 4YFN conference?

It’s a great chance to work in the ecosystem mindset I was mentioning earlier and to connect with other agents of this ecosystem to deliver the best digital innovation to our patients: startups and other companies, among others.

Is there anything else you want to share with us?

2023 will be a great year for Angelini Pharma with a lot of new impactful initiatives for our patients, especially in the Digital arena so… stay tuned!!

If you are interested in meeting Angelini Pharma, do not hesitate to visit the BHH Stand 8.1D30 in Hall 8 on Wednesday and Thursday. Barcelona Health Hub is already looking forward to meeting you! More information here.